Home Tags The New England Journal of Medicine

Tag: The New England Journal of Medicine

The state of cannabis research legislation in 2020

6/1/20--U.S. researchers lack appropriate access to commercially available cannabis products for clinical trials. Meanwhile, patients continue to use state-sanctioned products marketed as medicines in the absence of evidence to support their benefits or define their harms. Read

Vaping-induced lung disease — A look forward by looking back

4/23/20--In the current issue of The New England Journal of Medicine, an article by Werner and colleagues from the Centers for Disease Control and Prevention examines the outbreak of EVALI (e-cigarette, or vaping, product use–associated lung injury) and takes a look backward at this outbreak to see what we have learned. Although the EVALI crisis may now have faded, millions of e-cigarette users still have virtually no protection against the potential harms from the thousands of largely unregulated e-cigarette devices and liquids on the market. Read

Regulating vaping — policies, possibilities, and perils

3/25/20-- Use of e-cigarettes has recently soared, particularly among young people. Federal and state governments have implemented numerous policies to combat the growth of vaping. According to an article by Jody L. Sindelar published in The New England Journal of Medicine, policies should protect young people without diminishing the ability of e-cigarettes to help adult smokers transition away from more harmful combustible cigarettes or to serve as a cessation aid for people attempting to quit smoking. Read

Pulmonary illness related to e-cigarette use in Illinois and Wisconsin

9/6/19--In July 2019, the Wisconsin Department of Health Services and the Illinois Department of Public Health received reports of pulmonary disease associated with the use of e-cigarettes (also called vaping) and launched a coordinated public health investigation. Results indicate that although the features of e-cigarette use responsible for injury have not been identified, this cluster of illnesses represents an emerging clinical syndrome or syndromes. Additional work is needed to characterize the pathophysiology and to identify the definitive causes. Read

Vaping-Induced Lung Injury

9/6/19--The Centers for Disease Control and Prevention reported in late August 2019 that at least 215 acute, severe respiratory distress cases have been identified, spanning 25 states, and more recently at least 2 deaths have occurred. Although more investigation is needed to determine the vaping agent or agents responsible, there is clearly an epidemic that begs for an urgent response. Read

Imaging of vaping-associated lung disease

9/6/19--Lung injury associated with vaping has been recognized in the medical literature, and a case series of such injuries is now published in The New England Journal of Medicine. Four imaging patterns have been identified that correlated with pathological findings attributable to vaping, including acute eosinophilic pneumonia, diffuse alveolar damage, organizing pneumonia, and lipoid pneumonia. In addition, some cases were associated with variegated imaging patterns. Read